Picture of Australian Clinical Labs logo

ACL — Australian Clinical Labs News Story

0.000.00%
au flag iconLast trade - 00:00
HealthcareBalancedSmall CapSuper Stock

Brief: Australian Clinical Labs Announces FY2026 Interim Dividend Of 3.75 AU CPS

Feb 16 (Reuters) - Australian Clinical Labs Ltd ACL.AX:

FY2026 INTERIM DIVIDEND 3.75 AU CPS

H1 NET INCOME AUD 5.6 MILLION

H1 REVENUE AUD 365.4 MILLION

Further company coverage: ACL.AX

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Australian Clinical Labs

See all news